Siemens Healthcare Diagnostics today announced that Donal Quinn has been appointed to AdvaMed Dx's Board of Directors. Quinn joins an 18-member Board comprised of executives from leading diagnostic companies worldwide.   

AdvaMed Dx, a division of AdvaMed (Advanced Medical Technology Association), was recently formed to advance the public policy priorities of AdvaMed's diagnostic member companies and provide a dedicated vehicle that represents the interests of the in vitro diagnostics industry.  "I am extremely pleased to help support AdvaMed Dx in addressing the unique regulatory, legislative, reimbursement and legal issues facing the diagnostic industry," said Quinn. "I look forward to playing an integral role in the organization's success moving forward." 

"We are pleased to welcome Siemens as a member of AdvaMed Dx, and we look forward to having the benefit of Donal Quinn's leadership on the Board of Directors," said Steve Ubl, president and CEO of AdvaMed. "The interest in AdvaMed Dx by such industry leaders as Siemens is very encouraging, and I believe it demonstrates the need for a dedicated organization that is singularly focused on the advocacy priorities of in vitro diagnostics companies." 

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For further information please visit: www.siemens.com/healthcare.